Clinical Trial Update: Dendritic Cell-based Immunotherapy for Advanced Solid Tumours of Children and Young Adults [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating dendritic cell–based immunotherapy for advanced solid tumors in children and young adults has completed recruitment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Tumor
• Sarcoma

Snippet

Sponsor: Clinica Universidad de Navarra, Universidad de Navarra | Conditions: Sarcoma, Central Nervous System Tumor | Phase 1, Phase 2 | Status: COMPLETED